Integrum ABOSTO:INTEG B +2.17%54 Market Cap is kr226.41 Mil as of Jul. 10, 2026. GuruFocus rates OSTO:INTEG B with a GF Score™ of 54/100 and a GF Value™ of kr17.76 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Integrum AB ranks worse than 75.52% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Integrum AB's share price for the quarter that ended in Apr. 2026 was kr7.84. Integrum AB's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 26.67 Mil. Therefore, Integrum AB's market cap for the quarter that ended in Apr. 2026 was kr209.08 Mil.
Integrum AB's quarterly market cap
increased
from Oct. 2025 (kr181.35 Mil) to Jan. 2026 (kr263.75 Mil) but then
declined
from Jan. 2026 (kr263.75 Mil) to Apr. 2026 (kr209.08 Mil).
Integrum AB's annual market cap
declined
from Apr. 2024 (kr1,091.13 Mil) to Apr. 2025 (kr291.43 Mil) and
declined
from Apr. 2025 (kr291.43 Mil) to Apr. 2026 (kr209.08 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Integrum AB's Enterprise Value for Today is kr210.52 Mil.
Integrum AB (OSTO:INTEG B) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Integrum AB Market Cap Related Terms
Integrum AB Market Cap Historical Data
* Premium members only.
The historical data trend for Integrum AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:INTEG B vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, Integrum AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrum AB Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Integrum AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Integrum AB's Market Cap for the fiscal year that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrum AB (OSTO:INTEG B) has a Market Cap of kr226.41 Mil as of Jul. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Integrum AB and its competitors. According to the industry distribution chart, Integrum AB ranks #654 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 75.5%.
Is Integrum AB's Market Cap too high?
Integrum AB's current Market Cap is kr226.41 Mil. Based on the distribution chart, Integrum AB ranks #654 out of 866 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Integrum AB has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Integrum AB ranks #654 out of 866 companies for Market Cap. This places Integrum AB in the lower half of its industry. The industry median Market Cap is 116.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.25, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Integrum AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrum AB's current Market Cap is kr226.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (OSTO:INTEG B) is currently considered Possible Value Trap. The stock's GF Value™ is kr17.76, compared to a current price of kr8.49 — trading 52.2% below its estimated fair value. The current Market Cap is kr226.41 Mil. Integrum AB's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Integrum AB (OSTO:INTEG B), the current Market Cap is kr226.41 Mil as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrum AB (OSTO:INTEG B) Overvalued in 2026?
Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued.
The current stock price of kr8.49 is trading 52.2% below its estimated GF Value™ of kr17.76.
GuruFocus considers Integrum AB to be Possible Value Trap.
Key valuation signals for OSTO:INTEG B:
Market Cap: kr226.41 Mil
GF Value™: kr17.76 vs. price of kr8.49 (52.2% below fair value)
No single metric tells the full story. See the OSTO:INTEG B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
54GF Score
Get the complete analysis for OSTO:INTEG B
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:INTEG B has been successfully added to your 
